CASR and hyperphosphatemia: In addition, CaSR has been observed as a phosphate receptor in the parathyroid gland, and hyperphosphatemia, as a non-competitive inhibitor, inhibits its activity, thereby enhancing PTH production (Centeno et al., 2019).